Retroviral transfer of donor MHC class I or MHC class II genes into recipient bone marrow cells can induce operational tolerance to alloantigens in vivo.

Infusion of allogeneic, donor bone marrow (BM) can induce specific immunological unresponsiveness in vivo resulting in long-term acceptance of subsequent fully allogeneic, donor-type solid organ grafts, but this may be associated with graft-versus-host disease. We hypothesize that transfer of donor...

Full description

Bibliographic Details
Main Authors: Wong, W, Billing, J, Stranford, SA, Hyde, K, Fry, J, Morris, P, Wood, K
Format: Journal article
Language:English
Published: 2003
_version_ 1826261462645997568
author Wong, W
Billing, J
Stranford, SA
Hyde, K
Fry, J
Morris, P
Wood, K
author_facet Wong, W
Billing, J
Stranford, SA
Hyde, K
Fry, J
Morris, P
Wood, K
author_sort Wong, W
collection OXFORD
description Infusion of allogeneic, donor bone marrow (BM) can induce specific immunological unresponsiveness in vivo resulting in long-term acceptance of subsequent fully allogeneic, donor-type solid organ grafts, but this may be associated with graft-versus-host disease. We hypothesize that transfer of donor MHC gene(s) to recipient-type BM or hematopoietic stem cells would enable delivery of donor alloantigens to the recipient without the risk of graft-versus-host disease. This strategy could also potentially take advantage of linked suppression to induce specific unresponsiveness to additional alloantigens expressed by the solid organ graft. We found that infusion of 5 x 10(6) CBA (H-2(k)) recipient mouse BM cells transduced with a recombinant replication-defective retrovirus encoding either a single donor MHC class I or class II gene (H-2K(b) or H-2IA(b)) in combination with anti-CD4 monoclonal antibody resulted in long-term survival of C57BL/10 (H-2(b)) but not third-party NZW (H-2(z)) heart grafts. BM cells (3 x 10(3)) enriched for hematopoietic stem cells by sorting for c-Kit(+), lineage-negative cells, were able to induce long-term allograft survival in 50% of recipients after transduction with the vector encoding a single donor MHC class I gene. These results have important implications for future strategies to enhance clinical allograft survival by delivery of donor alloantigens.
first_indexed 2024-03-06T19:21:50Z
format Journal article
id oxford-uuid:1a5d15f8-40e7-446c-9647-d3633c291cea
institution University of Oxford
language English
last_indexed 2024-03-06T19:21:50Z
publishDate 2003
record_format dspace
spelling oxford-uuid:1a5d15f8-40e7-446c-9647-d3633c291cea2022-03-26T10:54:22ZRetroviral transfer of donor MHC class I or MHC class II genes into recipient bone marrow cells can induce operational tolerance to alloantigens in vivo.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:1a5d15f8-40e7-446c-9647-d3633c291ceaEnglishSymplectic Elements at Oxford2003Wong, WBilling, JStranford, SAHyde, KFry, JMorris, PWood, KInfusion of allogeneic, donor bone marrow (BM) can induce specific immunological unresponsiveness in vivo resulting in long-term acceptance of subsequent fully allogeneic, donor-type solid organ grafts, but this may be associated with graft-versus-host disease. We hypothesize that transfer of donor MHC gene(s) to recipient-type BM or hematopoietic stem cells would enable delivery of donor alloantigens to the recipient without the risk of graft-versus-host disease. This strategy could also potentially take advantage of linked suppression to induce specific unresponsiveness to additional alloantigens expressed by the solid organ graft. We found that infusion of 5 x 10(6) CBA (H-2(k)) recipient mouse BM cells transduced with a recombinant replication-defective retrovirus encoding either a single donor MHC class I or class II gene (H-2K(b) or H-2IA(b)) in combination with anti-CD4 monoclonal antibody resulted in long-term survival of C57BL/10 (H-2(b)) but not third-party NZW (H-2(z)) heart grafts. BM cells (3 x 10(3)) enriched for hematopoietic stem cells by sorting for c-Kit(+), lineage-negative cells, were able to induce long-term allograft survival in 50% of recipients after transduction with the vector encoding a single donor MHC class I gene. These results have important implications for future strategies to enhance clinical allograft survival by delivery of donor alloantigens.
spellingShingle Wong, W
Billing, J
Stranford, SA
Hyde, K
Fry, J
Morris, P
Wood, K
Retroviral transfer of donor MHC class I or MHC class II genes into recipient bone marrow cells can induce operational tolerance to alloantigens in vivo.
title Retroviral transfer of donor MHC class I or MHC class II genes into recipient bone marrow cells can induce operational tolerance to alloantigens in vivo.
title_full Retroviral transfer of donor MHC class I or MHC class II genes into recipient bone marrow cells can induce operational tolerance to alloantigens in vivo.
title_fullStr Retroviral transfer of donor MHC class I or MHC class II genes into recipient bone marrow cells can induce operational tolerance to alloantigens in vivo.
title_full_unstemmed Retroviral transfer of donor MHC class I or MHC class II genes into recipient bone marrow cells can induce operational tolerance to alloantigens in vivo.
title_short Retroviral transfer of donor MHC class I or MHC class II genes into recipient bone marrow cells can induce operational tolerance to alloantigens in vivo.
title_sort retroviral transfer of donor mhc class i or mhc class ii genes into recipient bone marrow cells can induce operational tolerance to alloantigens in vivo
work_keys_str_mv AT wongw retroviraltransferofdonormhcclassiormhcclassiigenesintorecipientbonemarrowcellscaninduceoperationaltolerancetoalloantigensinvivo
AT billingj retroviraltransferofdonormhcclassiormhcclassiigenesintorecipientbonemarrowcellscaninduceoperationaltolerancetoalloantigensinvivo
AT stranfordsa retroviraltransferofdonormhcclassiormhcclassiigenesintorecipientbonemarrowcellscaninduceoperationaltolerancetoalloantigensinvivo
AT hydek retroviraltransferofdonormhcclassiormhcclassiigenesintorecipientbonemarrowcellscaninduceoperationaltolerancetoalloantigensinvivo
AT fryj retroviraltransferofdonormhcclassiormhcclassiigenesintorecipientbonemarrowcellscaninduceoperationaltolerancetoalloantigensinvivo
AT morrisp retroviraltransferofdonormhcclassiormhcclassiigenesintorecipientbonemarrowcellscaninduceoperationaltolerancetoalloantigensinvivo
AT woodk retroviraltransferofdonormhcclassiormhcclassiigenesintorecipientbonemarrowcellscaninduceoperationaltolerancetoalloantigensinvivo